RecruitingNot ApplicableNCT06988943

Early Intervention Strategies for Lung Cancer

Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening


Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Enrollment

16,000 participants

Start Date

Jun 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.


Eligibility

Min Age: 40 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a structured early intervention strategy — including low-dose CT screening and follow-up care — can help detect lung cancer earlier in community health centers in Guangzhou, China. You may be eligible (as a patient) if: you are between 40 and 75 years old; you have lived in the study community for a long time; you have no known history of lung cancer and have not had lung cancer screening in the past 3 months; and you are willing and able to sign consent and participate in follow-up. You may NOT be eligible if: you have already been diagnosed with lung cancer; you have severe health conditions that make CT imaging unsafe; you cannot understand the study or give informed consent; or you are in another trial that may affect results. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELow-dose CT screening

Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination

DEVICEAI full-lung model interpretation system

Using artificial intelligence technology to assist in the interpretation of CT images

DEVICEDigital Health Platform

Community health centers and streets in Guangzhou use a program called "Fei Anxin" to manage residents' information in a unified way


Locations(1)

Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06988943


Related Trials